CVS Health Plans to Split Retail Pharmacy From Insurance and Pharmacy-Benefit Units by 2028
Photo: The New York TimesCVS Health said Wednesday, Nov. 4, that it will split into two companies, separating its retail pharmacy business from its insurance and pharmacy-benefit operations, with the separation expected to finish in the first half of 2028. One company will keep the CVS Health name and be led by CEO David Joyner. Prem Shah, group president, will be CEO of CVS Pharmacy. Joyner said the plan, made from a position of strength, aims to improve consumer engagement, affordability and care coordination. The Wall Street Journal reported the plan Tuesday, and the Financial Times had earlier reported that CVS was weighing a spinoff of its roughly 9,000 pharmacies while Aetna and Caremark stayed together. The move reverses a strategy built on acquisitions, including the roughly $78 billion Aetna purchase in 2018. It comes amid growing scrutiny from lawmakers and regulators of vertically integrated healthcare companies. CVS reported record 2025 revenue of $402.1 billion, up 7.8%.
The right-leaning New York Post calls the move a breakup of a healthcare empire. It builds the story on the Journal, Financial Times and Reuters reports, notes that CVS had not immediately responded to a request for comment, and adds financial context: the record revenue, the company's 2024 exploration of a breakup, and the share rebound under Joyner, who took over in October 2024. The left-leaning New York Times, in the excerpt provided, frames the split as the end of the healthcare conglomerate era. It stresses the 2028 timing and that insurance and pharmacy benefits stay together, and the excerpt gives no figures or named voices. Both sides agree on the basic structure of the split. They differ in emphasis: the Post on reported sourcing and company performance, the Times on what the split means for the industry model. Independent outlet MarketWatch adds that the decision surprised analysts.
How the sides differ Right sources stress reported sourcing, company finances and Joyner's turnaround; left sources frame the split as the end of the healthcare conglomerate model, with the 2028 timeline.
Headline, comparison and summary written by AI from the articles below. AI can make mistakes, so check the original articles before relying on a detail.
The New York Times frames the split as the end of the healthcare conglomerate era, highlighting the planned 2028 timing and the pairing of insurance and pharmacy benefits; the excerpt features no named voices.
MarketWatch stresses that the decision surprised analysts and asks what is driving it. Investing.com carries a Reuters report with Joyner's statement, Shah's role, the Aetna deal and regulatory scrutiny.
The New York Post leads with the breakup of a healthcare empire, relying on Wall Street Journal, Financial Times and Reuters reporting, and adds record revenue, the 9,000 pharmacies and Joyner's tenure.